Results 31 to 40 of about 34,408 (308)

Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users

Obstetrics and Gynecology, 2020
Copper intrauterine device users have a lower risk of high-grade cervical neoplasms compared with levonorgestrel-releasing intrauterine system users.
M. Spotnitz, K. Natarajan, P. B. Ryan, C. Westhoff   +3 more
semanticscholar   +1 more source

Seguridad y aceptabilidad del sistema intrauterino liberador de levonorgestrel 52 mg en mujeres con hemorragia uterina anormal en un centro de atención ambulatoria en Bogotá, Colombia, 2012-2016

Revista Colombiana de Obstetricia y Ginecología, 2020
Objetivo: describir la seguridad y aceptabilidad del uso del sistema intrauterino liberador de levonorgestrel de 52 mg en mujeres con hemorragia uterina anormal. Materiales y métodos: cohorte retrospectiva en la que se incluyeron mujeres de 18 años o más
Patricia Sandoval-Vivas
doaj   +1 more source

Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. [PDF]

, 2020
BackgroundThe levonorgestrel 52-mg intrauterine system has proven efficacy for heavy menstrual bleeding treatment in clinical trials, but few data exist to demonstrate how rapidly the effects occur and the effects in women with self-reported heavy ...
Chen, Beatrice A, Creinin, Mitchell D, Eisenberg, David L, Olariu, Andrea I, Schreiber, Courtney A, Turok, David K   +5 more
core  

Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding : systematic review and meta-analysis of data from individual patients [PDF]

, 2010
Peer reviewedPublisher ...
J. P. Daniels, K. G. Cooper, K. S. Khan, L. J. Middleton, M. Gannon, N. H. Hilken, null null, P. O'Donovan, R. Champaneria, R. Gray, S. Bhattacharya   +10 more
core   +2 more sources

Levonorgestrel-releasing intrauterine system vs. usual medical treatment for menorrhagia: An economic evaluation alongside a randomised controlled trial [PDF]

, 2014
Objective: To undertake an economic evaluation alongside the largest randomised controlled trial comparing Levonorgestrel-releasing intrauterine device ('LNG-IUS') and usual medical treatment for women with menorrhagia in primary care; and compare the ...
A Stewart, DG Whitehurst, Emma Frew, J Brazier, J Brazier, J Endrikat, J Gupta, Jane Daniels, Janesh Kumar Gupta, JH You, Joe Kai, JP Daniels, Laura Gennard, Lee Middleton, M Shapley, Maarten Postma, PD Blumenthal, Pelham Barton, R Brooks, R Hurskainen, S Sanghera, Sabina Sanghera, TE Roberts, Tracy Elizabeth Roberts   +23 more
core   +4 more sources

Reimann's "Habitual Hyperthermia" Responding to Hormone Therapy. [PDF]

, 2016
A 25-year-old woman presented with fever of unknown origin, exhibiting malaise and low-grade fevers in evenings. These fevers exhibited a pattern of starting mid-menstrual cycle with resolution around the onset of menses, matching a pattern of "habitual ...
Currier, Judith S, Yang, Otto O
core   +2 more sources

Exploring the Use of Cost-Benefit Analysis to Compare Pharmaceutical Treatments for Menorrhagia [PDF]

, 2015
Background: The extra-welfarist theoretical framework tends to focus on health-related quality of life, whilst the welfarist framework captures a wider notion of well-being.
D Husereau, DK Whynes, E McIntosh, Emma Frew, HA Glick, J Gupta, Janesh Kumar Gupta, Joe Kai, L Curtis, M Haefeli, M Shapley, MF Drummond, National Collaborating Centre for Women’s and Children’s Health, National Institute of Health and Clinical Excellence, National Institute of Health and Clinical Excellence, P Shackley, P Shackley, RD Smith, RD Smith, RW Shaw, S Birch, S Sanghera, S Sanghera, Sabina Sanghera, Tracy Elizabeth Roberts   +24 more
core   +4 more sources

Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial

Contraception: X, 2020
Objectives: Our primary objective was to compare geometric mean levonorgestrel concentrations between levonorgestrel implant users who were or were not taking the antiretroviral efavirenz, for up to 30 months after implant initiation.
Jennifer H. Tang, Nicole L. Davis, Amanda H. Corbett, Lameck Chinula, Mackenzie L. Cottrell, Yasaman Zia, Gerald Tegha, Frank Z. Stanczyk, Stacey Hurst, Mina C. Hosseinipour, Lisa B. Haddad, Athena P. Kourtis   +11 more
doaj  

Differential Effects of the Hormonal and Copper Intrauterine Device on the Endometrial Transcriptome. [PDF]

, 2020
The contraceptive effectiveness of intrauterine devices (IUDs) has been attributed in part to a foreign body reaction in the endometrium. We performed this study to better understand mechanisms of action of contraceptives of by studying their effects on ...
Averbach, Sarah, Giudice, Linda C, Houshdaran, Sahar, Seidman, Dominika, Smith-McCune, Karen, Takeda, Margaret, Thomas, Reuben   +6 more
core  

Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study

BMJ Open, 2019
Objectives To assess whether changes in patterns of combined oral contraceptive (COC) prescriptions to starters between 2008 and 2016 were in line with changes in national recommendations for use.Design Historical prospective cohort study.Setting The ...
Julie Ekman, Finn Egil Skjeldestad
doaj   +1 more source